PCM

Prelude Capital Management Portfolio holdings

AUM $1.02B
1-Year Return 30.93%
This Quarter Return
+7.63%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$1.46B
AUM Growth
+$309M
Cap. Flow
+$248M
Cap. Flow %
17%
Top 10 Hldgs %
11.02%
Holding
1,478
New
464
Increased
391
Reduced
281
Closed
264

Sector Composition

1 Technology 18.54%
2 Consumer Discretionary 13.5%
3 Healthcare 12.83%
4 Industrials 12.57%
5 Energy 9.03%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CCCC icon
1401
C4 Therapeutics
CCCC
$191M
-17,749
Closed -$100K
CCK icon
1402
Crown Holdings
CCK
$11B
-11,629
Closed -$1.07M
CDE icon
1403
Coeur Mining
CDE
$9.29B
-14,197
Closed -$46.3K
CFFN icon
1404
Capitol Federal Financial
CFFN
$862M
-16,907
Closed -$109K
CFG icon
1405
Citizens Financial Group
CFG
$22.8B
-11,401
Closed -$378K
CGEM icon
1406
Cullinan Oncology
CGEM
$416M
-17,844
Closed -$182K
CHE icon
1407
Chemed
CHE
$6.73B
-900
Closed -$526K
CHRW icon
1408
C.H. Robinson
CHRW
$15.1B
-3,856
Closed -$333K
CHTR icon
1409
Charter Communications
CHTR
$35.9B
-3,975
Closed -$1.55M
CLF icon
1410
Cleveland-Cliffs
CLF
$5.53B
-38,333
Closed -$783K
CMI icon
1411
Cummins
CMI
$55.7B
-1,261
Closed -$302K
CMRE icon
1412
Costamare
CMRE
$1.44B
-34,652
Closed -$361K
COHR icon
1413
Coherent
COHR
$15.5B
-18,000
Closed -$784K
COR icon
1414
Cencora
COR
$56.5B
-3,700
Closed -$760K
CRCT icon
1415
Cricut
CRCT
$1.25B
-38,984
Closed -$257K
CRH icon
1416
CRH
CRH
$75.4B
-4,507
Closed -$312K
CRK icon
1417
Comstock Resources
CRK
$4.67B
-164,493
Closed -$1.46M
CRS icon
1418
Carpenter Technology
CRS
$12.2B
-10,121
Closed -$717K
CRSP icon
1419
CRISPR Therapeutics
CRSP
$4.82B
0
CRTO icon
1420
Criteo
CRTO
$1.24B
-19,100
Closed -$484K
CSL icon
1421
Carlisle Companies
CSL
$17.1B
-698
Closed -$218K
CSTL icon
1422
Castle Biosciences
CSTL
$670M
-12,193
Closed -$263K
CVLT icon
1423
Commault Systems
CVLT
$7.98B
-2,704
Closed -$216K
DAC icon
1424
Danaos Corp
DAC
$1.72B
-3,742
Closed -$277K
DAWN icon
1425
Day One Biopharmaceuticals
DAWN
$760M
-42,500
Closed -$621K